Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 9/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | LSS | P48449 | 1/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.39 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16221514 | 0.91 | DPP4 (0.44) | DPP4DPP7MCHR1PDK2PDK4 | |
| SCHEMBL16211371 | 0.89 | SLC6A5 (0.41) | DPP4DPP7MCHR1PDK2PDK4 | |
| SCHEMBL16211388 | 0.89 | SLC6A5 (0.41) | DPP4DPP7MCHR1PDK2PDK4 | |
| SCHEMBL16211373 | 0.89 | SLC6A5 (0.41) | DPP4DPP7MCHR1PDK2PDK4 | |
| SCHEMBL16211265 | 0.89 | HDAC6 (0.48) | DPP4DPP7LSSHDAC6SLC6A5 | |
| SCHEMBL16211665 | 0.89 | HDAC6 (0.48) | DPP4DPP7LSSHDAC6SLC6A5 | |
| SCHEMBL16211267 | 0.89 | HDAC6 (0.48) | DPP4DPP7LSSHDAC6SLC6A5 | |
| SCHEMBL25981501 | 0.81 | HDAC6 (0.49) | MCHR1LSSHDAC6SLC6A5HDAC1 | |
| SCHEMBL25979867 | 0.79 | HDAC6 (0.47) | LSSHDAC6SLC6A5TEAD1HDAC1 | |
| SCHEMBL25979924 | 0.79 | SPHK2 (0.43) | DPP4DPP7MAOBPDK2PDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248735-A1 | COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2023-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248735-A1 | COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) | NR1H2, CFTR, CYP11B2 | DPP4 3323/4885DPP7 3071/4885MAOB 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.